Transcatheter versus surgical aortic valve replacement for severe aortic valve stenosis: Meta-analysis with trial sequential analysis
The Journal of Thoracic and Cardiovascular Surgery · 2025-04 · 169 (4) · 1214-1225.e5
DOI: 10.1016/j.jtcvs.2024.04.007 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025-04. Verfasst von Xander Jacquemyn und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Aortic Valve, Aortic Valve Stenosis, Heart Valve Prosthesis Implantation, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Belgian American Educational Foundation.
Abstract (Originalsprache)
OBJECTIVES: Randomized controlled trials comparing transcatheter aortic valve implantation with surgical aortic valve replacement demonstrate conflicting evidence, particularly in low-risk patients. We aim to reevaluate the evidence using trial sequential analysis, balancing type I and II errors, and compare with conventional meta-analysis. METHODS: Databases were searched for randomized controlled trials, which were divided into higher-risk and lower-risk randomized controlled trials according to a pragmatic risk classification. Primary outcomes were death and a composite end point of death or disabling stroke assessed at 1 year and maximum follow-up. Conventional meta-analysis and trial sequential analysis were performed, and the required information size was calculated considering a type I error of 5% and a power of 90%. RESULTS: Eight randomized controlled trials (n = 5274 higher-risk and 3661 lower-risk patients) were included. Higher-risk trials showed no significant reduction in death at 1 year with transcatheter aortic valve implantation (relative risk, 0.93, 95% CI, 0.81-1.08, P = .345). Lower-risk trials suggested lower death risk on conventional meta-analysis (relative risk, 0.67, 95% CI, 0.47-0.96, P = .031), but trial sequential analysis indicated potential spurious evidence (P = .116), necessitating more data for conclusive benefit (required information size = 5944 [59.8%]). For death or disabling stroke at 1 year, higher-risk trials lacked evidence (relative risk, 0.90, 95% CI, 0.79-1.02, P = .108). In lower-risk trials, transcatheter aortic valve implantation indicated lower risk in conventional meta-analysis (relative risk, 0.68, 95% CI, 0.50-0.93, P = .014), but trial sequential analysis suggested potential spurious evidence (P = .053), necessitating more data for conclusive benefit (required information size = 5122 [69.4%]). Follow-up results provided inconclusive evidence for both primary outcomes across risk categories. CONCLUSIONS: Conventional meta-analysis methods may have prematurely declared an early reduction of negative outcomes after transcatheter aortic valve implantation when compared with surgical aortic valve replacement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
- Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pa; UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pa.
- Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium; Department of Cardiac Surgery, University Hospitals Leuven, Leuven, Belgium.
- Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec City, Québec, Canada; Department of Medicine, Faculty of Medicine, Université Laval, Québec City, Québec, Canada.
- Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pa; UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pa. Electronic address: sultani@upmc.edu.
Förderung
- Belgian American Educational Foundation
Zitieren
APA
Jacquemyn, X., Sá, M. P., Rega, F., Verbrugghe, P., Meuris, B., Serna-Gallegos, D., Brown, J. A., Clavel, M. A., Pibarot, P., & Sultan, I. (2025). Transcatheter versus surgical aortic valve replacement for severe aortic valve stenosis: Meta-analysis with trial sequential analysis. The Journal of Thoracic and Cardiovascular Surgery, 169(4), 1214-1225.e5. https://doi.org/10.1016/j.jtcvs.2024.04.007
Vancouver
Jacquemyn X, Sá MP, Rega F, Verbrugghe P, Meuris B, Serna-Gallegos D, et al. Transcatheter versus surgical aortic valve replacement for severe aortic valve stenosis: Meta-analysis with trial sequential analysis. The Journal of Thoracic and Cardiovascular Surgery. 2025;169(4):1214-1225.e5. doi:10.1016/j.jtcvs.2024.04.007
BibTeX
@article{Jacquemyn2025,
author = {Jacquemyn, Xander and Sá, Michel Pompeu and Rega, Filip and Verbrugghe, Peter and Meuris, Bart and Serna-Gallegos, Derek and Brown, James A and Clavel, Marie-Annick and Pibarot, Philippe and Sultan, Ibrahim},
title = {Transcatheter versus surgical aortic valve replacement for severe aortic valve stenosis: Meta-analysis with trial sequential analysis},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2025},
volume = {169},
number = {4},
pages = {1214--1225.e5},
doi = {10.1016/j.jtcvs.2024.04.007}
}
EUVIMED